Total Payments
$452.16
2024 Payments
$257.43
Companies
4
Transactions
12
Medicare Patients
1,425
Medicare Billing
$136,073
Payment Breakdown by Category
Food & Beverage$452.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $452.16 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $226.02 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $151.22 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.14 | 4 | $0 (2021) |
| Braintree Laboratories, Inc. | $13.78 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.43 | 4 | Boston Scientific Corporation ($159.37) |
| 2023 | $53.16 | 2 | Regeneron Healthcare Solutions, Inc. ($53.16) |
| 2021 | $141.57 | 6 | BOSTON SCIENTIFIC CORPORATION ($66.65) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $50.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $106.25 | General |
| Category: EXALT Model D_ENDO | ||||||
| 07/02/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $53.12 | General |
| Category: EXALT Model D_ENDO | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $47.45 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 08/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $15.39 | General |
| 06/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/14/2021 | BOSTON SCIENTIFIC CORPORATION | RESOLUTION CLIP (Device) | Food and Beverage | In-kind items and services | $66.65 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | DEXILANT (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/25/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 470 | 513 | $370,975 | $46,006 |
| 2022 | 13 | 536 | 598 | $353,917 | $52,559 |
| 2021 | 13 | 376 | 412 | $217,148 | $34,236 |
| 2020 | 3 | 43 | 51 | $19,330 | $3,271 |
Total Patients
1,425
Total Services
1,574
Medicare Billing
$136,073
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 72 | $24,144 | $9,891 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 93 | $22,154 | $8,980 | 40.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $14,740 | $5,713 | 38.8% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 87 | 89 | $49,969 | $4,260 | 8.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $15,007 | $3,876 | 25.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 56 | 62 | $81,076 | $3,719 | 4.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 12 | 14 | $20,009 | $1,687 | 8.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 18 | $4,818 | $1,616 | 33.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 14 | 14 | $53,662 | $1,452 | 2.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 23 | $4,282 | $1,432 | 33.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $17,945 | $1,163 | 6.5% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2023 | 17 | 17 | $20,210 | $978.88 | 4.8% |
| 91040 | Study of esophageal sensation by balloon distension | Facility | 2023 | 19 | 19 | $25,784 | $632.52 | 2.5% |
| 91038 | Prolonged monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 15 | 15 | $17,175 | $604.40 | 3.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 55 | $14,920 | $7,539 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $16,628 | $7,474 | 44.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 41 | $15,750 | $6,477 | 41.1% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 118 | 119 | $57,052 | $5,968 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 76 | $60,359 | $4,776 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 50 | $10,001 | $4,467 | 44.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 49 | $8,917 | $3,900 | 43.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 65 | $8,329 | $3,678 | 44.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 30 | 30 | $92,396 | $3,152 | 3.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $20,622 | $2,023 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,348 | $1,597 | 36.7% |
About Dr. Chanakyaram Reddy, M.D
Dr. Chanakyaram Reddy, M.D is a Gastroenterology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2013. The National Provider Identifier (NPI) number assigned to this provider is 1235578220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chanakyaram Reddy, M.D has received a total of $452.16 in payments from pharmaceutical and medical device companies, with $257.43 received in 2024. These payments were reported across 12 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($452.16).
As a Medicare-enrolled provider, Reddy has provided services to 1,425 Medicare beneficiaries, totaling 1,574 services with total Medicare billing of $136,073. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Internal Medicine
- Location Dallas, TX
- Active Since 06/23/2013
- Last Updated 10/29/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235578220
Products in Payments
- EXALT Model D (Device) $159.37
- DUPIXENT (Biological) $103.77
- RESOLUTION CLIP (Device) $66.65
- EVKEEZA (Biological) $47.45
- MOTEGRITY (Drug) $17.78
- SUTAB (Drug) $13.78
- DEXILANT (Drug) $11.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dallas
Dr. Michael Brown, Md, MD
Gastroenterology — Payments: $6.0M
Gastroenterology $6.0M
Jay Horton, Md, MD
Gastroenterology — Payments: $419,727
Gastroenterology $419,727
Dr. Lawrence Schiller, Md, MD
Gastroenterology — Payments: $380,832
Gastroenterology $380,832
Dr. Jacqueline O'leary, Md, Mph, MD, MPH
Gastroenterology — Payments: $338,210
Gastroenterology $338,210
Dr. Byron Cryer, M.d, M.D
Gastroenterology — Payments: $331,404
Gastroenterology $331,404
Dr. Sami Arslanlar, Md, MD
Gastroenterology — Payments: $144,674
Gastroenterology $144,674